Charles Schwab’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-343,133
| Closed | -$25.8M | – | 3584 |
|
|
2022
Q2 | $25.8M | Sell |
343,133
-8,061
| -2% | -$607K | 0.01% | 1210 |
|
|
2022
Q1 | $9.43M | Buy |
351,194
+6,399
| +2% | +$172K | ﹤0.01% | 1991 |
|
|
2021
Q4 | $16.4M | Buy |
344,795
+8,185
| +2% | +$390K | ﹤0.01% | 1721 |
|
|
2021
Q3 | $22.4M | Buy |
336,610
+16,916
| +5% | +$1.12M | 0.01% | 1495 |
|
|
2021
Q2 | $24.9M | Buy |
319,694
+26,467
| +9% | +$2.06M | 0.01% | 1407 |
|
|
2021
Q1 | $27.7M | Buy |
293,227
+23,984
| +9% | +$2.27M | 0.01% | 1252 |
|
|
2020
Q4 | $32.8M | Buy |
269,243
+34,421
| +15% | +$4.19M | 0.01% | 1042 |
|
|
2020
Q3 | $20.5M | Buy |
234,822
+85,554
| +57% | +$7.47M | 0.01% | 1187 |
|
|
2020
Q2 | $9.64M | Buy |
149,268
+31,378
| +27% | +$2.03M | ﹤0.01% | 1670 |
|
|
2020
Q1 | $5.27M | Buy |
117,890
+1,625
| +1% | +$72.6K | ﹤0.01% | 1806 |
|
|
2019
Q4 | $7.24M | Buy |
116,265
+44,962
| +63% | +$2.8M | ﹤0.01% | 1833 |
|
|
2019
Q3 | $2.68M | Buy |
71,303
+20,397
| +40% | +$767K | ﹤0.01% | 2282 |
|
|
2019
Q2 | $2.07M | Buy |
+50,906
| New | +$2.07M | ﹤0.01% | 2359 |
|